NIKKEI 225
28,157.17 -125.86 (-0.44%) HANG SENG
17,225.41 -348.17 (-1.98%) CRUDE OIL
74.06 -2.22 (-2.91%) GOLD FUTURES
1,749.50 -4.50 (-0.26%) DOW
34,347.03 +152.93 (+0.45%) BTC-GBP
13,436.68 -347.65 (-2.52%)
NantHealth, Inc. (NH)
| Previous close | 0.2761 |
| Open | 0.2890 |
| Bid | 0.2746 x 800 |
| Ask | 0.3100 x 3100 |
| Day's range | 0.2827 - 0.2890 |
| 52-week range | 0.1710 - 1.3400 |
| Volume | |
| Avg. volume | 74,200 |
| Market cap | 32.712M |
| Beta (5Y monthly) | 2.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5100 |
| Earnings date | 22 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.00 |
- Simply Wall St.
NantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)
NantHealth ( NASDAQ:NH ) Third Quarter 2022 Results Key Financial Results Revenue: US$16.6m (up 16% from 3Q 2021). Net...
- Business Wire
NantHealth Reports 2022 Third Quarter Financial Results
MORRISVILLE, N.C., November 03, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its third quarter ended September 30, 2022.
- Business Wire
NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3
MORRISVILLE, N.C., October 31, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
